Discovery Europe 2023

Day One

Discovery on Target and Phenotypic based Discovery 

Stream 1: Identification & Validation of Novel Targets 

Stream 2: Animal and Disease Modelling, Organoid based Discovery, Organ On Chip development, 3D Media 

Stream 3: Discovery on Target – Screening and Genomic Strategies

Drug Design and Medicinal Chemistry  

Stream 4:  Computational Drug Design  

Afternoon Interactive Panel Sessions: 

• Identification and Validating Novel Targets  
• Target Discovery and Animal Modelling  
• ML on optimising and improving DELs  
• AI in Drug Design – Where Are We? 
• Digitising Drug Discovery Labs 

• Chemical Biology Approaches for Target ID and Target Discovery 
• Challenges and Opportunities Pursuing RNA as a Drug Target 

 Day Two

Stream 4: Drug Discovery Innovation Showcase: Enabling Innovation And Collaboration   

Malcom Weir - Executive Officer, Bice President at Sosei Heptares

Ulrich Betz - Vice President Innovation, Head of Department Innovation Incubator at Merck

Matthias Frech - Director Molecular Interactions & Biophysics at Merck

Clara Christ - Head of Computational Molecular Design at Bayer

Oliver Nosjean - Head of Open Innovation and Scientific Affairs, R&D at Servier

Nadeem Sarwar - Global Head, Genomic Stategies & Global Head, Digital Therapeutics (DTx) Strategies at Elsai